Vitae

Home > Vitae

Andy Yeh Alpha

Virtual net portfolio value:$5,918,863

Net overall return per annum:26.48%

Dan Rochefort

Virtual net portfolio value:$3,925,724

Net overall return per annum:19.80%

Rose Prince

Virtual net portfolio value:$3,756,854

Net overall return per annum:19.11%

Peter Prince

Virtual net portfolio value:$3,706,886

Net overall return per annum:18.90%

Jonah Whanau

Virtual net portfolio value:$3,695,076

Net overall return per annum:18.85%

Daisy Harvey

Virtual net portfolio value:$3,636,291

Net overall return per annum:18.59%

James Campbell

Virtual net portfolio value:$3,616,346

Net overall return per annum:18.51%

Olivia London

Virtual net portfolio value:$3,586,114

Net overall return per annum:18.38%

Jacob Miramar

Virtual net portfolio value:$3,511,641

Net overall return per annum:18.05%

John Fourier

Virtual net portfolio value:$3,500,674

Net overall return per annum:18.00%

Laura Hermes

Virtual net portfolio value:$3,463,036

Net overall return per annum:17.83%

Joseph Corr

Virtual net portfolio value:$3,459,720

Net overall return per annum:17.82%

Fiona Sydney

Virtual net portfolio value:$3,436,333

Net overall return per annum:17.71%

Becky Berkman

Virtual net portfolio value:$3,416,622

Net overall return per annum:17.62%

Charlene Vos

Virtual net portfolio value:$3,415,702

Net overall return per annum:17.62%

Monica McNeil

Virtual net portfolio value:$3,407,406

Net overall return per annum:17.58%

Apple Boston

Virtual net portfolio value:$3,371,478

Net overall return per annum:17.42%

Chanel Holden

Virtual net portfolio value:$3,335,984

Net overall return per annum:17.25%

Blog+More

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Rose Prince

2018-10-15 09:33:00 Monday ET

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties such as cardiovascular medications an

+See More

The great reversal of antitrust merger review in America

Monica McNeil

2023-10-07 10:24:00 Saturday ET

The great reversal of antitrust merger review in America

Thomas Philippon draws attention to greater antitrust scrutiny in light of the rise of market power and its economic ripple effects. Thomas Philippon (20

+See More

AYA finbuzz podcast offers fresh insights into the latest stock market topics and economic trends for better stock investment decisions.

Amy Hamilton

2019-08-31 14:39:00 Saturday ET

AYA finbuzz podcast offers fresh insights into the latest stock market topics and economic trends for better stock investment decisions.

AYA Analytica finbuzz podcast channel on YouTube August 2019 In this podcast, we discuss several topical issues as of August 2019: (1) Warren B

+See More

Trump advisor Gary Cohn aims for tax neutrality over the next decade.

Charlene Vos

2017-02-25 06:44:00 Saturday ET

Trump advisor Gary Cohn aims for tax neutrality over the next decade.

As the White House economic director, Gary Cohn suggests that the Trump administration will tackle tax cuts after the administration *repeals and replaces*

+See More

Our proprietary alpha investment model outperforms most stock market indices from 2017 to 2021.

Apple Boston

2021-02-02 14:24:00 Tuesday ET

Our proprietary alpha investment model outperforms most stock market indices from 2017 to 2021.

Our proprietary alpha investment model outperforms the major stock market benchmarks such as S&P 500, MSCI, Dow Jones, and Nasdaq. We implement

+See More

Goldman Sachs chief economist Jan Hatzius proposes designing a new Financial Conditions Index (FCI).

Chanel Holden

2018-07-19 18:38:00 Thursday ET

Goldman Sachs chief economist Jan Hatzius proposes designing a new Financial Conditions Index (FCI).

Goldman Sachs chief economist Jan Hatzius proposes designing a new Financial Conditions Index (FCI) to be a weighted-average of interest rates, exchange rat

+See More